Drug Approval | May 19, 2026
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
The target reach is of more than 30 million young people and caregivers across 21 countries
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
NEJM study shows strong protection across strains
Subscribe To Our Newsletter & Stay Updated
